Showing results (161-170 of 168) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Angewandte Chemie (International Ed. in English)|April 28, 2020
Discovery of a Novel Mycobacterial F-ATP Synthase Inhibitor and its Potency in Combination with DiarylquinolinesAdam Hotra, Priya Ragunathan, Pearly Shuyi Ng, et al.Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.Bioorganic & Medicinal Chemistry Letters|November 15, 2008
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological resultsArkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, et al.ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 2025
Next-generation rifamycins for the treatment of mycobacterial infectionsVéronique Dartois, Tian Lan, Uday S Ganapathy, et al.ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.Science Translational Medicine|December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosisSrinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.Pageof 17